Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy

American Journal of Respiratory and Critical Care Medicine

Volumn 172, Issue 6, 2005, Pages 704-712

  Usmani, Omar S ^a   Ito, Kazuhiro ^a   Maneechotesuwan, Kittipong ^a   Ito, Misako ^a   Johnson, Malcolm ^a   Barnes, Peter J ^a   Adcock, Ian M ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Asthma; Human; Lung; Therapy; Transcription factors

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; GLUCOCORTICOID RECEPTOR; SALMETEROL;

ADULT; ARTICLE; ASTHMA; CELL LINE; CELL NUCLEUS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOCYTOCHEMISTRY; LUNG ALVEOLUS CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RANDOMIZED CONTROLLED TRIAL;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; BECLOMETHASONE; BIOLOGICAL TRANSPORT; BRONCHODILATOR AGENTS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CELL LINE; CELL NUCLEUS; CYTOPLASM; DRUG THERAPY, COMBINATION; FEMALE; GENES, REPORTER; HUMANS; IMMEDIATE-EARLY PROTEINS; LUCIFERASES; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN-TYROSINE-PHOSPHATASE; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; RECEPTORS, GLUCOCORTICOID; RESPONSE ELEMENTS; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SPUTUM; TRANSCRIPTION, GENETIC;

EID: 24944482440     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200408-1041OC     Document Type: Article

References (49)

1. Barnes PJ. Inhaled glucocorticoids for asthma. W Engl J Med 1995;332:868-875.
2. Beato M, Herrlich P, Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell 1995;83:851-857.
3. Barnes PJ, Adcock IM. Transcription factors and asthma. Eur Respir J 1998;12:221-234.
4. Karin M. New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell 1998;93:487-490.
5. Ito K, Barnes PJ, Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 2000;20:6891-6903.
6. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 1994;344:219-224.
7. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405-1411.
8. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996;153:1481-1488.
9. Shrewsbury S, Pyke S, Britton M. Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). BMJ 2000;320:1368-1373.
10. Matz J, Emmett A, Rickard K, Kalberg C. Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations. J Allergy Clin Immunol 2001;107:783-789.
11. Juniper EF, Svensson K, O'Byrne PM, Barnes PJ, Bauer CA, Lofdahl CG, Postma DS, Pauwels RA, Tattersfield AE, Ullman A. Asthma quality of life during 1 year of treatment with budesonide with or without formoterol. Eur Respir J 1999;14:1038-1043.
12. Barnes PJ. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and Corticosteroids. Eur Respir J 2002;19:182-191.
13. Johnson M. Combination therapy for asthma: complementary effects of long-acting beta-2 agonists and corticosteroids. Curr Allergy Clin Immunol 2002;15:16-22.
14. Eickelberg O, Roth M, Lorx R, Bruce V, Rudiger J, Johnson M, Block LM. Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem 1999;274:1005-1010.
15. Roth M, Johnson PR, Rudiger JJ, King GG, Ge Q, Burgess JK, Anderson G, Tamm M, Black JL. Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Lancet 2002;360:1293-1299.
16. Roth M, Rüdiger JJ, Bihl MP, Leufgen H, Cornelius BC, Gencay M. The β2-agonist formoterol activates the glucocorticoid receptor in vivo [abstract]. Eur Respir J 2000;16:437S.
17. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;143:1433-1437.
18. Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997;155:542-548.
19. Hoshi H, Ohno I, Honma M, Tanno Y, Yamauchi K, Tamura G, Shirato K. IL-5, IL-8 and GM-CSF immunostaining of sputum cells in bronchial asthma and chronic bronchitis. Clin Exp Allergy 1995;25:720-728.
20. Sackey FN, Hache RJ, Reich T, Kwast-Welfeld J, Lefebvre YA. Determinants of subcellular distribution of the glucocorticoid receptor. Mol Endocrinol 1996;10:1191-1205.
21. van Steensel B. Brink M, van der Meulen K, van Binnendijk EP, Wansink DG, de Jong L, de Kloet ER, van Driel R. Localization of the glucocorticoid receptor in discrete clusters in the cell nucleus. J Cell Sci 1995;108:3003-3011.
22. Adcock IM, Nasuhara Y, Stevens DA, Barnes PJ. Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement. Br J Pharmacol 1999;127:1003-1011.
23. Engelbecht Y, de Wet H, Horch K, Langeveldt CR, Hough FS, Hulley PA. Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines. Endocrinology 2003;144:412-422.
24. Adcock IM, Gilbey T, Gelder CM, Chung KF, Barnes PJ. Glucocorticoid receptor localization in normal and asthmatic lung. Am J Respir Crit Care Med 1996;154:771-782.
25. Lemiere C, Taha R, Olivenstein R, Hamid Q. Comparison of cellular composition of induced sputum analyzed with Wright staining and immunocytochemistry. J Allergy Clin Immunol 2001;108:521-523.
26. Busse WW, Chervinsky P, Condemi J, Lumry WR, Petty TL, Rennard S, Townley RG. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol 1998;101:457-463.
27. Korn S, Jerre A, Brattsand R. Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells. Eur Respir J 2001;17:1070-1077.
28. Pang L, Knox AJ. Synergistic inhibition by β2-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells. Am J Respir Cell Mol Biol 2000;23:79-85.
29. Pang L, Knox AJ. Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids. FASEB J 2001;15:261-269.
30. Li X, Ward C, Thien F, Bish R, Bamford T, Bao X, Bailey M, Wilson JW, Walters EH. An antiinflammatory effect of salmeterol, a long-acting β2 agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma. Am J Respir Crit Care Med 1999;160:1493-1499.
31. Orsida BE, Ward C, Li X, Bish R, Wilson JW, Thien F, Walters EH. Effect of a long-acting β2-agonist over three months on airway wall vascular remodeling in asthma. Am J Respir Crit Care Med 2001;164:117-121.
32. Chung KF, Barnes PJ. Cytokines in asthma. Thorax 1999;54:825-857.
33. Hu JM, Bodwell JE, Munck A. Control by basal phosphorylation of cell cycle-dependent, hormone-induced glucocorticoid receptor hyperphosphorylation. Mol Endocrinol 1997;11:305-311.
34. Irusen E, Matthews JG, Takahashi A, Barnes PJ, Chung KF, Adcock IM. p38 mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J Allergy Clin Immunol 2002;109:649-657.
35. DeFranco DB, Qi M, Horror KC, Garabedian MJ, Brautigan DL. Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors. Mol Endocrinol 1991;5:1215-1228.
36. Dean DA, Urban G, Aragon IV, Swingle M, Miller B, Rusconi S, Bueno M, Dean NM, Honkanen RE. Serine/threonine protein phosphatase 5 (PP5) participates in the regulation oi glucocorticoid receptor nucleocytoplasmic shuttling. BMC Cell Biol 2001;2:6.
37. Galigniana MD, Housley PR, DeFranco DB, Pratt WB. Inhibition of glucocorticoid receptor nucleocytoplasmic shuttling by okadaic acid requires intact cytoskeleton. J Biol Chem 1999;274:16222-16227.
38. Doucas V, Shi Y, Miyamoto S, West A, Verma I, Evans RM. Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 2000;97:11893-11898.
39. Adcock IM, Maneechotesuwan K, Usmani O. Molecular interactions between glucocorticoids and long-acting β2-agonists. J Allergy Clin Immunol 2002;110:S261-S268.
40. Daaka Y, Luttrell LM, Lefkowitz RJ. Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A. Nature 1997;390:88-91.
41. Kido H, Fukusen N, Katunuma N. Inhibition by 1-(5-isoquinolinesulfonyl)- 2-methylpiperazine, an inhibitor of protein kinase C, of enzyme induction by glucocorticoid and of nuclear translocation of glucocorticoid-receptor complexes. Biochem Biophys Res Commun 1987;144:152-159.
42. Hancox RJ, Stevens DA, Adcock IM, Barnes PJ, Taylor DR. Effects of inhaled beta agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma. Thorax 1999;54.488-492.
43. Madan AP, DeFranco DB. Bidirectional transport of glucocorticoid receptors across the nuclear envelope. Proc Natl Acad Sci USA 1993;90:3588-3592.
44. Bodwell JE, Hu JM. Hu LM, Munck A. Glucocorticoid receptors: ATP and cell cycle dependence, phosphorylation, and hormone resistance. Am J Respir Crit Care Med 1996;154:S2-S6.
45. Catt KJ, Harwood JP, Aguilera G, Dufau ML. Hormonal regulation of peptide receptors and target cell responses. Nature 1979;280:109-116.
46. Vanderbilt JN, Miesfeld R, Maler BA, Yamamoto KR. Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol Endocrinol 1987;1:68-74.
47. Bloomfield CD, Smith KA, Peterson BA, Munck A. Glucocorticoid receptors in adult acute lymphoblastic leukemia. Cancer Res 1981:41:4857-4860.
48. Schleimer RP. Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Respir Dis 1990;141:S59-S69.
49. Strickland I, Kisich K, Hauk PJ, Vottero A, Chrousos GP, Klemm DJ, Leung DY. High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J Exp Med 2001;193:585-594.